RCKT EPS Estimates
Rocket Pharmaceuticals, Inc.
$2.36
+$0.15(+6.79%)
37
Overall
60
Value
36
Tech
15
Quality
Market Cap
$242.60M
Volume
1.88M
52W Range
$2.42 - $5.45
Target Price
$8.21
RCKT EPS estimates: the consensus estimate for Rocket Pharmaceuticals, Inc.'s current fiscal year is -$1.36 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
RCKT EPS Estimates
- EPS estimate, current quarter
- $-0.39
- EPS estimate, next quarter
- $-0.39
- EPS estimate, current year
- $-1.36
- EPS estimate, next year
- $-1.44
- EPS growth, 3-year
- +14.89%
| Fiscal year | EPS |
|---|---|
| 2025 | $-2.01 |
| 2024 | $-2.73 |
| 2023 | $-2.92 |
| 2022 | $-3.26 |
| 2021 | $-2.67 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RCKT | $2.36 | +6.8% | 1.88M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Rocket Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW